Inhaled corticosteroid (prodrug)
Pregnancy: Considered safe — inhaled corticosteroids preferred over uncontrolled asthma in pregnancy.
Ciclesonide
Brand names: Alvesco
Adult dose
Dose: Asthma: 80–160 mcg OD; severe disease 160 mcg BD (max 640 mcg/day).
Route: Inhalation (HFA pMDI)
Frequency: Once daily (preferred) or twice daily
Max: 640 mcg/day
Activated by esterases in airway epithelium — minimal oropharyngeal deposition; mouth rinsing not strictly required (but still good practice).
Paediatric dose
Route: Inhalation
Frequency: Once daily
≥12 yrs: adult dose. Not licensed under 12 in UK (limited data). Spacer recommended.
Clinical pearls
- Once-daily ICS dosing improves adherence vs BD — useful for patients struggling with twice-daily regimens.
- Prodrug — activated by airway esterases to des-ciclesonide; minimal active drug in oropharynx → lower thrush/dysphonia rates than beclometasone or fluticasone.
- Equivalent low-dose ICS (BTS/SIGN): ciclesonide 160 mcg/day ≈ beclometasone (Clenil) 400 mcg/day ≈ fluticasone 200 mcg/day.
- Useful when oral candidiasis or dysphonia limits other ICS — common in elderly, professional voice users.
- Reasonable alternative if patient cannot tolerate other ICS but rarely needs to be a first-choice agent.
- Always ensure step-up review and inhaler technique check before stepping up dose.
Contraindications
- Hypersensitivity to ciclesonide
- Untreated active TB or fungal pulmonary infection (relative)
Side effects
- Lower oral candidiasis and dysphonia rates than older ICS (prodrug activation in the airways means less oropharyngeal deposition)
- Headache, nasopharyngitis
- Paradoxical bronchospasm (rare)
- Adrenal suppression at high doses (less than equivalent dose of beclometasone — better systemic safety)
- Skin thinning, easy bruising (long-term high-dose)
- Cataracts, glaucoma (long-term)
- Behavioural changes (rare)
Interactions
- CYP3A4 inhibitors (ritonavir, ketoconazole, clarithromycin, itraconazole): ↑ systemic exposure — caution
- Beta-blockers: ↑ asthma exacerbation risk
Monitoring
- Asthma control test
- Adrenal axis if high dose
Reference: BNFc; BNF 90; SmPC Alvesco; BTS/SIGN Asthma 158 (2019); GINA 2024. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- COPD Exacerbation Management · NICE NG115 / GOLD 2024
- Community-Acquired Pneumonia (CURB-65) · BTS 2009 / NICE NG138
- Acute Pulmonary Embolism · BTS 2003 / ESC 2019
- Pleural Effusion Assessment · BTS 2010